Alothman Danah, Card Timothy, Lewis Sarah, Tyrrell Edward, Fogarty Andrew W, Marshall Charles R
School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Preventive Neurology Unit, Wolfson Institute of Population Health, London, United Kingdom.
JAMA Neurol. 2022 Oct 3;79(11):1148-54. doi: 10.1001/jamaneurol.2022.3094.
Patients with dementia may be at an increased suicide risk. Identifying groups at greatest risk of suicide would support targeted risk reduction efforts by clinical dementia services.
To examine the association between a dementia diagnosis and suicide risk in the general population and to identify high-risk subgroups.
DESIGN, SETTING, AND PARTICIPANTS: This was a population-based case-control study in England conducted from January 1, 2001, through December 31, 2019. Data were obtained from multiple linked electronic records from primary care, secondary care, and the Office for National Statistics. Included participants were all patients 15 years or older and registered in the Office for National Statistics in England with a death coded as suicide or open verdict from 2001 to 2019. Up to 40 live control participants per suicide case were randomly matched on primary care practice and suicide date.
Patients with codes referring to a dementia diagnosis were identified in primary care and secondary care databases.
Odds ratios (ORs) were estimated using conditional logistic regression and adjusted for sex and age at suicide/index date.
From the total sample of 594 674 patients, 580 159 (97.6%) were controls (median [IQR] age at death, 81.6[72.0-88.4] years; 289 769 male patients [50.0%]), and 14 515 (2.4%) died by suicide (median [IQR] age at death, 47.4 [36.0-59.7] years; 10 850 male patients [74.8%]). Among those who died by suicide, 95 patients (1.9%) had a recorded dementia diagnosis (median [IQR] age at death, 79.5 [67.1-85.5] years; median [IQR] duration of follow-up, 2.3 [1.0-4.4] years). There was no overall significant association between a dementia diagnosis and suicide risk (adjusted OR, 1.05; 95% CI, 0.85-1.29). However, suicide risk was significantly increased in patients diagnosed with dementia before age 65 years (adjusted OR, 2.82; 95% CI, 1.84-4.33), in the first 3 months after diagnosis (adjusted OR, 2.47; 95% CI, 1.49-4.09), and in patients with dementia and psychiatric comorbidity (adjusted OR, 1.52; 95% CI, 1.21-1.93). In patients younger than 65 years and within 3 months of diagnosis, suicide risk was 6.69 times (95% CI, 1.49-30.12) higher than in patients without dementia.
Diagnostic and management services for dementia, in both primary and secondary care settings, should target suicide risk assessment to the identified high-risk groups.
痴呆症患者的自杀风险可能会增加。识别出自杀风险最高的群体将有助于临床痴呆症服务机构有针对性地开展降低风险的工作。
研究普通人群中痴呆症诊断与自杀风险之间的关联,并识别高危亚组。
设计、背景和参与者:这是一项基于人群的病例对照研究,于2001年1月1日至2019年12月31日在英格兰进行。数据来自初级保健、二级保健以及国家统计局的多个关联电子记录。纳入的参与者为所有15岁及以上、在英格兰国家统计局注册且2001年至2019年期间死亡编码为自杀或存疑裁决的患者。每个自杀病例最多随机匹配40名存活对照参与者,匹配因素为初级保健机构和自杀日期。
在初级保健和二级保健数据库中识别出有痴呆症诊断编码的患者。
使用条件逻辑回归估计比值比(OR),并根据自杀/索引日期时的性别和年龄进行调整。
在594674名患者的总样本中,580159名(97.6%)为对照(死亡时年龄中位数[四分位间距]为81.6[72.0 - 88.4]岁;男性患者289769名[50.0%]),14515名(2.4%)死于自杀(死亡时年龄中位数[四分位间距]为47.4[36.0 - 59.7]岁;男性患者10850名[74.8%])。在死于自杀的患者中,95名(1.9%)有痴呆症诊断记录(死亡时年龄中位数[四分位间距]为79.5[67.1 - 85.5]岁;随访时间中位数[四分位间距]为2.3[1.0 - 4.4]年)。痴呆症诊断与自杀风险之间总体无显著关联(调整后的OR为1.05;95%置信区间为0.85 - 1.29)。然而,65岁之前被诊断为痴呆症的患者自杀风险显著增加(调整后的OR为2.82;95%置信区间为1.84 - 4.33),诊断后的前3个月内自杀风险显著增加(调整后的OR为2.47;95%置信区间为1.49 - 4.09),患有痴呆症且有精神疾病合并症的患者自杀风险显著增加(调整后的OR为1.52;95%置信区间为1.21 - 1.93)。在65岁以下且诊断后3个月内的患者中,自杀风险比无痴呆症患者高6.69倍(95%置信区间为1.49 - 30.12)。
初级保健和二级保健机构中的痴呆症诊断和管理服务应将自杀风险评估针对已识别出的高危群体。